Advertisements


Biotech Analysis Central Pharma News: Pfizer"s Unit Separation, BioCryst"s Merger Collapses, Scynexis" Positive Mid-Stage Results

Biotech Analysis Central Pharma News: Pfizer"s Unit Separation, BioCryst"s Merger Collapses, Scynexis" Positive Mid-Stage Results.....»»

Category: topSource: seekingalphaJul 12th, 2018

Biotech Analysis Central Pharma News: Zogenix"s Late-Stage Win, Zynerba"s Bounce Back, Abbvie"s Expanded Venetoclax Use

Biotech Analysis Central Pharma News: Zogenix"s Late-Stage Win, Zynerba"s Bounce Back, Abbvie"s Expanded Venetoclax Use.....»»

Category: topSource: seekingalphaJul 16th, 2018

Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead"s Early Stage Bet, Vaxart"s Phase 2 Failure

Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead"s Early Stage Bet, Vaxart"s Phase 2 Failure.....»»

Category: topSource: seekingalphaJun 6th, 2018

Biotech Analysis Central Pharma News: Synthetic Loses Designation, Sage Files NDA , Alnylam Gets Positive Opinion From EMA

Biotech Analysis Central Pharma News: Synthetic Loses Designation, Sage Files NDA , Alnylam Gets Positive Opinion From EMA.....»»

Category: topSource: seekingalphaApr 24th, 2018

Biotech Analysis Central Pharma News: Celgene"s Protocol Change, Roche"s BLA For Herceptin, Amgen"s Resubmission For Osteoporosis

Biotech Analysis Central Pharma News: Celgene"s Protocol Change, Roche"s BLA For Herceptin, Amgen"s Resubmission For Osteoporosis.....»»

Category: topSource: seekingalphaJul 16th, 2018

Biotech Analysis Central Pharma News: Cytodyn"s Acquisition, Novartis Exits Antibotic Research, Advaxis" FDA Hold Removed

Biotech Analysis Central Pharma News: Cytodyn"s Acquisition, Novartis Exits Antibotic Research, Advaxis" FDA Hold Removed.....»»

Category: topSource: seekingalphaJul 15th, 2018

Zogenix shares soar 19% premarket after news of positive trial for severe epilepsy treatment

Zogenix Inc. shares soared about 19% in premarket trade Thursday, after the biotech reported positive results in a late-stage trial of a treatment for the severe form of epilepsy, Dravet syndrome, in children and yo.....»»

Category: topSource: marketwatchJul 12th, 2018

Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori"s Mixed ED Data

Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori"s Mixed ED Data.....»»

Category: topSource: seekingalphaJul 10th, 2018

Biotech Analysis Central Pharma News: Puma"s Reversal Win, Pain Therapeutics Suffers Major Blow, Achaogen"s FDA Score

Biotech Analysis Central Pharma News: Puma"s Reversal Win, Pain Therapeutics Suffers Major Blow, Achaogen"s FDA Score.....»»

Category: topSource: seekingalphaJun 27th, 2018

Biotech Analysis Central Pharma News: CytoDyn"s BLA Update, Anika"s Failure, Vertex"s Expansion Of Facility

Biotech Analysis Central Pharma News: CytoDyn"s BLA Update, Anika"s Failure, Vertex"s Expansion Of Facility.....»»

Category: topSource: seekingalphaJun 25th, 2018

Biotech Analysis Central Pharma News: Takeda"s Acquisition Win, Ionis And Akcea Tumble, Alnylam"s Advance In CNS

Biotech Analysis Central Pharma News: Takeda"s Acquisition Win, Ionis And Akcea Tumble, Alnylam"s Advance In CNS.....»»

Category: topSource: seekingalphaMay 9th, 2018

Biotech Analysis Central Pharma News: Takeda Raises Shire Bid, Daiichi Fails DMD Trial, Celldex Cuts 20% Of Workforce

Biotech Analysis Central Pharma News: Takeda Raises Shire Bid, Daiichi Fails DMD Trial, Celldex Cuts 20% Of Workforce.....»»

Category: topSource: seekingalphaApr 26th, 2018

Biotech Analysis Central Pharma News: Orexigen"s Last Resort, Epizyme"s Partial Clinical Hold, Eli Lilly And Incyte"s Mixed Advisory Panel Vote

Biotech Analysis Central Pharma News: Orexigen"s Last Resort, Epizyme"s Partial Clinical Hold, Eli Lilly And Incyte"s Mixed Advisory Panel Vote.....»»

Category: topSource: seekingalphaApr 24th, 2018

Biotech Analysis Central Pharma News: Biogen"s Deal, Eli Lilly Partner Incyte Refile Baricitinib, Argos Loses Out

Biotech Analysis Central Pharma News: Biogen"s Deal, Eli Lilly Partner Incyte Refile Baricitinib, Argos Loses Out.....»»

Category: topSource: seekingalphaApr 23rd, 2018

Biotech Analysis Central Pharma News: J&J Scraps Antibiotic Program, Novartis Siponimod, GW Pharma"s Major Support By Panel

Biotech Analysis Central Pharma News: J&J Scraps Antibiotic Program, Novartis Siponimod, GW Pharma"s Major Support By Panel.....»»

Category: topSource: seekingalphaApr 23rd, 2018

Biotech Analysis Central Pharma News: Merck"s Keytruda Breakthrough, Bristol Myers And JNJ Team Up, Alkermes Gets A Second Shot

Biotech Analysis Central Pharma News: Merck"s Keytruda Breakthrough, Bristol Myers And JNJ Team Up, Alkermes Gets A Second Shot.....»»

Category: topSource: seekingalphaApr 17th, 2018

Biotech Analysis Central Pharma News: GlaxoSmithKline Passes Along Pipeline, Pulse Impresses, Celldex"s Failure

Biotech Analysis Central Pharma News: GlaxoSmithKline Passes Along Pipeline, Pulse Impresses, Celldex"s Failure.....»»

Category: topSource: seekingalphaApr 17th, 2018

Biotech Analysis Central Pharma News: Novartis"s Gene Therapy Catch, AstraZeneca"s NASH Move, Clovis"s Expanded Rubraca Market

Biotech Analysis Central Pharma News: Novartis"s Gene Therapy Catch, AstraZeneca"s NASH Move, Clovis"s Expanded Rubraca Market.....»»

Category: topSource: seekingalphaApr 11th, 2018

Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost

Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost.....»»

Category: topSource: seekingalphaApr 9th, 2018

Benzinga"s Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 10) Bio-Rad Laboratories, Inc. (NYSE: BIO) BioXcel Th.....»»

Category: earningsSource: benzingaJul 11th, 2018

Benzinga"s Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 10) read more.....»»

Category: blogSource: benzingaJul 11th, 2018